The myth of “leaner and meaner” pharma
Pascal Soriot, chief executive officer of AstraZeneca, poses for a photograph outside the Houses of Commons on May 13, 2014 Bloomberg/Getty
Is pharma shedding employees to protect and grow the bottom line? Judging from the headlines, you might think so. But actually, instead of getting “leaner and meaner,” most big drug companies are getting fatter and softer — and a result, pharma’s human capital efficiency has been mostly stagnant.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
